New MRI techniques aim to spot hidden cancers in high-risk families
NCT ID NCT03176836
First seen May 07, 2026 · Last updated Jun 05, 2026 · Updated 4 times
Summary
This pilot study tests whether advanced MRI scans can detect very small tumors and tell them apart from harmless growths in people with Li-Fraumeni Syndrome (LFS), a genetic condition that greatly increases cancer risk. About 30 participants with a known TP53 mutation will undergo special imaging. The goal is to improve early detection, not to treat or cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LI-FRAUMENI SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.